Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
Authors
Keywords
-
Journal
Neurocritical Care
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-06
DOI
10.1007/s12028-020-01161-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factor Xa Inhibitor-Related Intracranial Hemorrhage
- (2020) Nicholas G. Panos et al. CIRCULATION
- Evaluation of andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) for reversal of rivaroxaban‐ and apixaban‐associated intracranial hemorrhages
- (2020) Megan E. Barra et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of Low- Versus High-Dose Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Factor Xa Inhibitor–Associated Bleeding: A Retrospective Study
- (2020) H Andrew Wilsey et al. JOURNAL OF INTENSIVE CARE MEDICINE
- 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2020) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study
- (2019) Melanie N. Smith et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding
- (2019) Miriam Kimpton et al. Hematology-American Society of Hematology Education Program
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
- (2015) Deborah M. Siegal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
- (2015) J. Claude Hemphill et al. STROKE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining hematoma expansion in intracerebral hemorrhage: Relationship with patient outcomes
- (2011) D. Dowlatshahi et al. NEUROLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now